新生児呼吸窮迫症候群治療の世界市場レポート 2025年

新生児呼吸窮迫症候群治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で14億1,000万米ドルに成長します。予測期間中の成長は、付属品や消耗品の需要増加、NICU入室の増加、個別化医療のニーズの高まり、早産率の上昇、研究開発活動の拡大などの要因によるものと考えられます。予測期間に予想される主な動向には、新生児集中治療室（NICU）の自動化、人工知能（AI）の統合、新生児ケア技術の進歩、界面活性剤療法の革新、高度な人工呼吸器技術の開発などがあります。

早産の増加により、新生児呼吸窮迫症候群（NRDS）治療市場の拡大が見込まれています。早産は、赤ちゃんが妊娠37週未満に生まれた場合に発生し、一般的な妊娠は約40週続くため、32週未満に生まれた赤ちゃんは最大の健康リスクに直面します。早産の増加は、母体年齢の上昇、多胎妊娠、病状、ライフスタイルの選択、不妊治療、感染症、環境の影響などの要因によるものです。新生児呼吸窮迫症候群は、肺が未発達でサーファクタントの産生が不十分なため、未熟児によくみられます。新生児呼吸窮迫症候群の治療は、肺機能を改善し、呼吸を安定させ、早産児の呼吸不全のリスクを下げるのに役立ちます。例えば、英国を拠点とする慈善団体Tommy'sは2022年12月に、イングランドとウェールズにおける早産児の割合が2021年の7.5％から2022年には7.9％に増加し、2年連続で早産児が増加し、その年の早産児は5万3,000人を超えたと報告しました。その結果、未熟児出産の増加がNRDS治療市場の成長に拍車をかけています。

新生児呼吸窮迫症候群治療市場の主要企業は、酸素化を改善し、呼吸合併症を軽減し、低酸素性呼吸不全の新生児に非侵襲的な治療オプションを提供するために、一酸化窒素発生器などの先進技術の開発に注力しています。一酸化窒素発生装置は、一酸化窒素ガスを発生・投与する装置であり、特に新生児や重症患者において、酸素化を促進し肺高血圧を軽減することで呼吸器系の問題を治療するために使用されます。例えば、2022年6月、米国の医療機器・バイオ医薬品会社であるビヨンド・エアー社は、同社のラングフィットPHのFDA承認を取得しました。この革新的な一酸化窒素発生装置は、新生児の遷延性肺高血圧症（PPHN）を含む低酸素性呼吸不全の新生児やそれに近い新生児を治療するために設計されています。この装置は、ビヨンド・エアの特許技術であるイオナイザー技術を利用し、周囲の空気からオンデマンドで一酸化窒素を生成するため、投与量や流量を気にすることなく連続供給が可能です。また、低電力コンプレッサーを使用して窒素と酸素をイオン化し、二酸化窒素（NO2）の発生を最小限に抑え、スマートフィルターを使用して安全にろ過します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界新生児呼吸窮迫症候群治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の新生児呼吸窮迫症候群治療市場：成長率分析
• 世界の新生児呼吸窮迫症候群治療市場の実績：規模と成長, 2019-2024
• 世界の新生児呼吸窮迫症候群治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界新生児呼吸窮迫症候群治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の新生児呼吸窮迫症候群治療市場：セラピー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酸素療法
• サーファクタント療法
• 世界の新生児呼吸窮迫症候群治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口
• 吸入
• その他の投与経路
• 世界の新生児呼吸窮迫症候群治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 亜急性期施設
• ホームケア
• 小売薬局
• 世界の新生児呼吸窮迫症候群治療市場酸素療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の酸素療法
• 高流量鼻カニューラ（HFNC）酸素療法
• 持続的陽圧呼吸（CPAP）酸素療法
• 酸素療法を伴う侵襲的人工呼吸
• 世界の新生児呼吸窮迫症候群治療市場サーファクタント療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然界面活性剤
• 合成界面活性剤
• 複合サーファクタント療法（天然＋合成）
• 予防的サーファクタント療法
• レスキューサーファクタント療法

第7章 地域別・国別分析

• 世界の新生児呼吸窮迫症候群治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の新生児呼吸窮迫症候群治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 新生児呼吸窮迫症候群治療市場：競合情勢
• 新生児呼吸窮迫症候群治療市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medline Industries
• Becton Dickinson
• Stryker Corporation
• GE Healthcare
• Koninklijke Philips NV
• ResMed Inc.
• Dragerwerk AG & Co. KGaA
• Chiesi Farmaceutici
• ICU Medical Inc.
• Fisher & Paykel Healthcare
• Vyaire Medical
• Laerdal Medical
• Hamilton Medical
• Inspiration Healthcare
• Ventec Life Systems

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 新生児呼吸窮迫症候群治療市場2029：新たな機会を提供する国
• 新生児呼吸窮迫症候群治療市場2029：新たな機会を提供するセグメント
• 新生児呼吸窮迫症候群治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Neonatal respiratory distress syndrome (NRDS) treatment focuses on managing premature infants who experience breathing difficulties due to inadequate surfactant production. This treatment typically includes the administration of exogenous surfactant therapy, respiratory support through mechanical ventilation or continuous positive airway pressure (CPAP), and oxygen supplementation.

The primary treatments for neonatal respiratory distress syndrome are oxygen therapy and surfactant therapy. Oxygen therapy involves supplying oxygen to patients who struggle to get enough oxygen through normal breathing. It can be delivered via parenteral routes, inhalation, or other methods, and is used in hospitals, sub-acute facilities, home care settings, and retail pharmacies.

The neonatal respiratory distress syndrome treatment market research report is one of a series of new reports from The Business Research Company that provides neonatal respiratory distress syndrome treatment market statistics, including neonatal respiratory distress syndrome treatment industry global market size, regional shares, competitors with a neonatal respiratory distress syndrome treatment market share, detailed neonatal respiratory distress syndrome treatment market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal respiratory distress syndrome treatment industry. This neonatal respiratory distress syndrome treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neonatal respiratory distress syndrome treatment market size has grown strongly in recent years. It will grow from $0.96 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to factors such as the rising permeability and fluid accumulation in the alveoli, an increase in alveolar-capillary permeability, a higher utilization of mechanical ventilation, greater awareness among healthcare providers and parents about the importance of neonatal care, and increased investments in healthcare.

The neonatal respiratory distress syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to factors such as the rising demand for accessories and consumables, an increase in NICU admissions, a growing need for personalized medicine, a higher rate of premature births, and expanding research and development activities. Key trends expected in the forecast period include the automation of neonatal intensive care units (NICUs), the integration of artificial intelligence (AI), advancements in neonatal care technology, innovations in surfactant therapy, and the development of advanced ventilator technologies.

The growing incidence of premature births is expected to drive the expansion of the neonatal respiratory distress syndrome (NRDS) treatment market. Premature birth, or preterm birth, occurs when a baby is born before 37 weeks of pregnancy, with those born before 32 weeks facing the greatest health risks, as a typical pregnancy lasts about 40 weeks. The rise in premature births is attributed to factors such as advancing maternal age, multiple pregnancies, medical conditions, lifestyle choices, fertility treatments, infections, and environmental influences. Neonatal respiratory distress syndrome is commonly seen in premature infants due to their underdeveloped lungs and insufficient surfactant production. Treatment for NRDS helps improve lung function, stabilize breathing, and lower the risk of respiratory failure in preterm babies. For example, Tommy's, a UK-based charity, reported in December 2022 that the percentage of premature live births in England and Wales increased to 7.9% in 2022 from 7.5% in 2021, marking a second consecutive year of rising premature births, with over 53,000 babies born prematurely that year. As a result, the growing incidence of premature births is fueling the growth of the NRDS treatment market.

Leading companies in the neonatal respiratory distress syndrome treatment market are focusing on the development of advanced technologies such as nitric oxide generators to improve oxygenation, reduce respiratory complications, and provide non-invasive treatment options for neonates with hypoxic respiratory failure. A nitric oxide generator is a device that produces and administers nitric oxide gas, which is used to treat respiratory issues by enhancing oxygenation and reducing pulmonary hypertension, especially in neonates and critically ill patients. For example, in June 2022, Beyond Air Inc., a US-based medical device and biopharmaceutical company, received FDA approval for its LungFit PH. This innovative nitric oxide generator is designed to treat term and near-term neonates with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device utilizes Beyond Air's patented Ionizer technology to generate nitric oxide on demand from ambient air, providing a continuous supply without concerns about dosage or flow. It also uses a low-power compressor to ionize nitrogen and oxygen, minimizing the production of nitrogen dioxide (NO2), which is then safely filtered out using a smart filter.

In January 2024, Chiesi Group, an Italy-based biopharmaceutical company, entered into a partnership with Oak Hill Bio to advance neonatal therapies. This collaboration aims to develop and commercialize OHB-607, an innovative treatment designed to prevent severe bronchopulmonary dysplasia (BPD) and its long-term respiratory complications in preterm infants, especially those born before 28 weeks gestational age with low IGF-1 levels. Oak Hill Bio is a UK-based company focused on developing treatments for neonatal and rare diseases.

Major players in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Dragerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., and Lyomark Pharma GmbH.

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neonatal respiratory distress syndrome treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neonatal respiratory distress syndrome treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neonatal respiratory distress syndrome treatment market consists of revenues earned by entities by providing services such as surfactant administration services, neonatal respiratory care consulting, telemedicine, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal respiratory distress syndrome treatment market also includes sales of mechanical ventilators, continuous positive airway pressure (CPAP) machines, high-frequency ventilators, and neonatal incubators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neonatal Respiratory Distress Syndrome Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neonatal respiratory distress syndrome treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neonatal respiratory distress syndrome treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neonatal respiratory distress syndrome treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy: Oxygen Therapy; Surfactant Therapy
• 2) By Route Of Administration: Parenteral; Inhalation; Other Routes Of Administration
• 3) By End User: Hospitals; Sub-Acute Facilities; Home Care; Retail Pharmacies
• Subsegments:
• 1) By Oxygen Therapy: Conventional Oxygen Therapy; High-Flow Nasal Cannula (HFNC) Oxygen Therapy; Continuous Positive Airway Pressure (CPAP) Oxygen Therapy; Invasive Mechanical Ventilation With Oxygen Therapy
• 2) By Surfactant Therapy: Natural Surfactants; Synthetic Surfactants; Combined Surfactant Therapy (Natural + Synthetic); Prophylactic Surfactant Therapy; Rescue Surfactant Therapy
• Companies Mentioned:Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Abbott Laboratories; Medtronic Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neonatal Respiratory Distress Syndrome Treatment Market Characteristics

3. Neonatal Respiratory Distress Syndrome Treatment Market Trends And Strategies

4. Neonatal Respiratory Distress Syndrome Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Neonatal Respiratory Distress Syndrome Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neonatal Respiratory Distress Syndrome Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neonatal Respiratory Distress Syndrome Treatment Market Growth Rate Analysis
• 5.4. Global Neonatal Respiratory Distress Syndrome Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neonatal Respiratory Distress Syndrome Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neonatal Respiratory Distress Syndrome Treatment Total Addressable Market (TAM)

6. Neonatal Respiratory Distress Syndrome Treatment Market Segmentation

• 6.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxygen Therapy
• Surfactant Therapy
• 6.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Inhalation
• Other Routes Of Administration
• 6.3. Global Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Sub-Acute Facilities
• Home Care
• Retail Pharmacies
• 6.4. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Oxygen Therapy
• High-Flow Nasal Cannula (HFNC) Oxygen Therapy
• Continuous Positive Airway Pressure (CPAP) Oxygen Therapy
• Invasive Mechanical Ventilation With Oxygen Therapy
• 6.5. Global Neonatal Respiratory Distress Syndrome Treatment Market, Sub-Segmentation Of Surfactant Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Surfactants
• Synthetic Surfactants
• Combined Surfactant Therapy (Natural + Synthetic)
• Prophylactic Surfactant Therapy
• Rescue Surfactant Therapy

7. Neonatal Respiratory Distress Syndrome Treatment Market Regional And Country Analysis

• 7.1. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neonatal Respiratory Distress Syndrome Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market

• 8.1. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neonatal Respiratory Distress Syndrome Treatment Market

• 9.1. China Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 9.2. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neonatal Respiratory Distress Syndrome Treatment Market

• 10.1. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neonatal Respiratory Distress Syndrome Treatment Market

• 11.1. Japan Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 11.2. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neonatal Respiratory Distress Syndrome Treatment Market

• 12.1. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market

• 13.1. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neonatal Respiratory Distress Syndrome Treatment Market

• 14.1. South Korea Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 14.2. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market

• 15.1. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 15.2. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neonatal Respiratory Distress Syndrome Treatment Market

• 16.1. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neonatal Respiratory Distress Syndrome Treatment Market

• 17.1. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neonatal Respiratory Distress Syndrome Treatment Market

• 18.1. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neonatal Respiratory Distress Syndrome Treatment Market

• 19.1. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neonatal Respiratory Distress Syndrome Treatment Market

• 20.1. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market

• 21.1. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 21.2. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neonatal Respiratory Distress Syndrome Treatment Market

• 22.1. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neonatal Respiratory Distress Syndrome Treatment Market

• 23.1. North America Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 23.2. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neonatal Respiratory Distress Syndrome Treatment Market

• 24.1. USA Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 24.2. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neonatal Respiratory Distress Syndrome Treatment Market

• 25.1. Canada Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 25.2. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neonatal Respiratory Distress Syndrome Treatment Market

• 26.1. South America Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 26.2. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neonatal Respiratory Distress Syndrome Treatment Market

• 27.1. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neonatal Respiratory Distress Syndrome Treatment Market

• 28.1. Middle East Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 28.2. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neonatal Respiratory Distress Syndrome Treatment Market

• 29.1. Africa Neonatal Respiratory Distress Syndrome Treatment Market Overview
• 29.2. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neonatal Respiratory Distress Syndrome Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape And Company Profiles

• 30.1. Neonatal Respiratory Distress Syndrome Treatment Market Competitive Landscape
• 30.2. Neonatal Respiratory Distress Syndrome Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis

31. Neonatal Respiratory Distress Syndrome Treatment Market Other Major And Innovative Companies

• 31.1. Medline Industries
• 31.2. Becton Dickinson
• 31.3. Stryker Corporation
• 31.4. GE Healthcare
• 31.5. Koninklijke Philips NV
• 31.6. ResMed Inc.
• 31.7. Dragerwerk AG & Co. KGaA
• 31.8. Chiesi Farmaceutici
• 31.9. ICU Medical Inc.
• 31.10. Fisher & Paykel Healthcare
• 31.11. Vyaire Medical
• 31.12. Laerdal Medical
• 31.13. Hamilton Medical
• 31.14. Inspiration Healthcare
• 31.15. Ventec Life Systems

32. Global Neonatal Respiratory Distress Syndrome Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neonatal Respiratory Distress Syndrome Treatment Market

34. Recent Developments In The Neonatal Respiratory Distress Syndrome Treatment Market

35. Neonatal Respiratory Distress Syndrome Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neonatal Respiratory Distress Syndrome Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer